An Early Feasibility, Prospective, Single-Arm Study of the Polaris System
NCT ID: NCT06990074
Last Updated: 2026-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2025-09-23
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Refractive Outcomes Utilizing Two SS-OCT Biometers for IOL Power Calculations
NCT06801678
Assessment of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery
NCT04747834
CAtaract ASSessment of IntrOcular Lens Objective PErformancE
NCT06168617
Conventional Surgery vs. Verion/VerifEye
NCT02513745
Phacoemulsification and Intraocular Lens Implantation: Patient Registry
NCT07276217
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Polaris System is intended to enhance precision and safety over the current standard of care by employing improved stability controls and augmented visualization properties, enabling safer surgical decisions and finer control of surgical instruments.
This study will be conducted at up to 3 research sites. After the informed consent process, potential participants will be considered enrolled in the study and undergo the screening evaluation. Following confirmation of eligibility, selected participants will be sequentially assigned to undergo robot-assisted cataract surgery and receive four scheduled follow-ups over 90 days, post-intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants with age-related uncomplicated cataract
Single eye cataract robot-assisted cataract surgery.
Participants will receive intraoperative eye preparation according to the standard of care for cataract surgery. Under general anesthesia, a docking procedure between the study eye and the medical device will be completed. The surgeon will use the Polaris System to perform initial surgical tasks and perform the initial portion of the affected lens extraction. Finally, the surgeon will use the Polaris System to complete the lens extraction and perform the final surgical tasks, including the intraocular lens implantation.
cataract surgery
Robot-assisted cataract surgery
cataract surgery
Robot-assisted cataract surgery, designed to provide superior precision and increase the safety profile of the current standard of care.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cataract surgery
Robot-assisted cataract surgery
cataract surgery
Robot-assisted cataract surgery, designed to provide superior precision and increase the safety profile of the current standard of care.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A slit-lamp diagnosis of uncomplicated, age-related visually significant cataract that is not posterior polar or congenital
* Eligible to undergo cataract extraction by phacoemulsification with intraocular lens (IOL) implantation
* Able and willing to comply with all study procedures
* Able to return for scheduled follow-up examinations
* Willing to adhere to the prescribed medication regimen (to prevent inflammation and infection)
* Provision of signed and dated informed consent form
Exclusion Criteria
* Posterior polar or congenital cataract
* Previous history of vitrectomy, corneal, refractive, or cataract surgery
* Concurrent participation in another ophthalmological clinical study
* Allergies to any medications required in surgery, pre- and post-operative treatment
* Diagnosis of corneal disease or pathology that precludestransmission of optical coherence tomography (OCT) laser wavelength (e.g., corneal opacity), distorts OCT laser light (e.g., corneal scarring or history of radial keratotomy), or compromises engagement of the patient interface (e.g., megalocornea or pterygium), in the opinion of the Investigator
* History of poor pupil dilation, demonstration of poor reaction to pupil-dilation drugs (minimum 7 mm dilation should be targeted for study), diagnosis of a pupillary defect that precludes the iris from adequate peripheral retraction, and/or diagnosis of floppy iris syndrome or iris dyscoria
* Current or prior use of concomitant medications known to cause floppy iris syndrome (e.g., alpha-blockers, such as Flomax)
* Compromised cornea (e.g., Fuchs endothelial dystrophy)
* History of lens or zonular instability
* Immunocompromised or diagnosis of ophthalmic disease: ocular herpes zoster or simplex, lupus, collagenosis or other acute or chronic illnesses that increase the risk to the subject or confounds the outcomes of this study, in the opinion of the Investigator
* Developmental disability or cognitive impairment that would make informed consent and the assessment of visual acuity impossible, in the opinion of the Investigator
* History of significant ocular trauma
* History of iritis or uveitis
* Pregnant women, as confirmed via urine pregnancy test for women of child-bearing age at screening
40 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Horizon Surgical Systems Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinica Quesada SA de CV
San Salvador, San Salvador Department, El Salvador
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.